Signs you're using too high a concentration include persistent redness, increased sensitivity to other products, dryness that doesn't respond to moisturizer, and skin that looks worse rather than better over time
Each batch is reviewed for: Accurate dosing (to ensure each capsule delivers 500 mcg of active BPC-157) Absence of heavy metals or contaminants Microbial safety This type of transparency is increasingly important in a market where many peptide products are either under-dosed or entirely unverified
Apply these five checks to the popular claim retatrutide is far better than cagrilintide and it quickly reduces to: a 48-week top-dose monotherapy number for one, next to a 26-week monotherapy number for the other whose real strength is a combination with no head-to-head trial anywhere in the chain
For tirzepatide, this means starting at 2.5 mg weekly for four weeks
Everything gets here very quickly and very efficiently
Always defer to the specific peptide's research literature